|
End-of-day quote
Nasdaq
2026-10-20
|
5-day change | 1st Jan Change | ||
| 1.670 USD | +5.70% |
|
0.00% | -81.51% |
| 10-15 | EnGene Therapeutics Inc. - Special Call | |
| 09-20 | EnGene Therapeutics Inc.(NasdaqCM:ENGN) dropped from S&P Global BMI Index | CI |
Stock exchange
Quotes 5-day view: enGene Therapeutics Inc.
End-of-day quote Nasdaq| 2026-10-19 | 2026-10-20 | 2026-10-21 | 2026-10-22 | 2026-10-23 | |
|---|---|---|---|---|---|
| Last | US$1.580 | US$1.670 | US$1.630 | US$1.580 | US$1.560 |
| Volume | 783,845 | 1,119,792 | 1,108,892 | 554,578 | 730,199 |
| Change | -5.39% | +5.70% | -2.40% | -3.07% | -1.27% |
| Opening | US$1.660 | US$1.600 | US$1.680 | US$1.619 | US$1.550 |
| High | US$1.700 | US$1.720 | US$1.681 | US$1.650 | US$1.575 |
| Low | US$1.580 | US$1.590 | US$1.590 | US$1.570 | US$1.540 |
Performance
| 1 day | +5.70% | ||
| Current month | -16.50% | ||
| 1 month | -13.02% | ||
| 3 months | -8.24% | ||
| 6 months | -79.10% | ||
| Current year | -81.51% | ||
| 1 year | -79.79% | ||
| 3 years | -90.82% |
Volumes
marketsDaily volume
1,119,792
Avg. Volume 20 sessions
885,656
Avg. Volume 20 sessions USD
1,479,045.52
Record volume 1
51,454,331
Record volume 2
24,102,681
Record volume 3
17,386,929
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
104,545,452
Net sales (USD)
0
Free-Float
99.89%
Free-Float capitalization (USD)
104,429,736
Average Daily Capital Traded
1.41%
Indicators
Moving average 5 days
1.64
Moving average 20 days
1.81
Moving average 50 days
1.83
Moving average 100 days
1.8
Price spread / (MMA5)
-1.80%
Price spread / (MMA20)
+8.38%
Price spread / (MMA50)
+9.58%
Price spread / (MMA100)
+7.78%
STIM
RSI 9 days
43.12
RSI 14 days
42.79
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.70% | 0.00% | -79.79% | -90.82% | 105M | |
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | |
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | |
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | |
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | |
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | |
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | |
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | |
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | |
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | |
| Average | +0.82% | +2.88% | +35.29% | +117.72% | 38.32B | |
| Weighted average by Cap. | +0.39% | +2.73% | +45.98% | +142.77% |
Historical Quotes: enGene Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 1.54 |  | 1.72 |
| 1 month | 1.54 | | 2.02 |
| Current year | 1.4 | | 12.25 |
| 1 year | 1.4 | | 12.25 |
| 3 years | 1.4 | | 47.17 |
| 5 years | 1.4 | | 47.17 |
| 10 years | 1.4 | | 47.17 |
Monthly variations
Annual variations
| 2026 | -82.72% | ||
| 2025 | +35.79% | ||
| 2024 | -27.95% | ||
| 2023 | -10.65% | ||
| 2022 | +4.77% |
- Stock Market
- Stocks
- ENGN Stock
- Quotes enGene Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
